136 related articles for article (PubMed ID: 31852562)
1. Impact of molecular testing on reported
Ilieş I; Benneyan JC; Jabur TBC; Baker AW; Anderson DJ
Infect Control Hosp Epidemiol; 2020 Mar; 41(3):306-312. PubMed ID: 31852562
[TBL] [Abstract][Full Text] [Related]
2. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
Humphries RM; Uslan DZ; Rubin Z
J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection.
Xuan S; Zangwill KM; Ni W; Ma J; Hay JW
J Gen Intern Med; 2020 Apr; 35(4):1102-1110. PubMed ID: 32016703
[TBL] [Abstract][Full Text] [Related]
4. Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates.
Moehring RW; Lofgren ET; Anderson DJ
Infect Control Hosp Epidemiol; 2013 Oct; 34(10):1055-61. PubMed ID: 24018922
[TBL] [Abstract][Full Text] [Related]
5. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates.
Alrawashdeh M; Rhee C; Hsu H; Wang R; Horan K; Lee GM
JAMA Netw Open; 2021 Oct; 4(10):e2132114. PubMed ID: 34714336
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
Miller R; Morillas JA; Brizendine KD; Fraser TG
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
[TBL] [Abstract][Full Text] [Related]
8. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection.
Gould CV; Edwards JR; Cohen J; Bamberg WM; Clark LA; Farley MM; Johnston H; Nadle J; Winston L; Gerding DN; McDonald LC; Lessa FC;
Clin Infect Dis; 2013 Nov; 57(9):1304-7. PubMed ID: 23899677
[TBL] [Abstract][Full Text] [Related]
9. Impact of the introduction of nucleic acid amplification testing on Clostridioides difficile detection and ribotype distribution in Wales.
Perry MD; White PL; Morris TE
Anaerobe; 2021 Feb; 67():102313. PubMed ID: 33309680
[TBL] [Abstract][Full Text] [Related]
10. Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States.
Cohen J; Limbago B; Dumyati G; Holzbauer S; Johnston H; Perlmutter R; Dunn J; Nadle J; Lyons C; Phipps E; Beldavs Z; Clark LA; Lessa FC;
J Clin Microbiol; 2014 Feb; 52(2):632-4. PubMed ID: 24478500
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see?
Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Pisapia R; Gärtner B; Berger FK; Reigadas E; Bouza E; Demont C; Wilcox MH
Anaerobe; 2020 Apr; 62():102178. PubMed ID: 32092415
[TBL] [Abstract][Full Text] [Related]
12. Implementing a Clostridium difficile testing algorithm and its effect on isolation duration and treatment initiation: a pre- and post-implementation study.
Vogelzang EH; Lankelma JM; van Mansfeld R; van Prehn J; van Houdt R
Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1071-1076. PubMed ID: 31970532
[TBL] [Abstract][Full Text] [Related]
13. Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset
McCormick WL; Jackson G; Andrea SB; Whitehead V; Chargualaf TL; Touzard-Romo F
Infect Control Hosp Epidemiol; 2024 Jan; 45(1):106-109. PubMed ID: 37424227
[TBL] [Abstract][Full Text] [Related]
14. Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm.
Schultz K; Sickbert-Bennett E; Marx A; Weber DJ; DiBiase LM; Campbell-Bright S; Bode LE; Baker M; Belhorn T; Buchanan M; Goldbach S; Harden J; Hoke E; Huenniger B; Juliano JJ; Langston M; Ritchie H; Rutala WA; Smith J; Summerlin-Long S; Teal L; Gilligan P
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29997201
[TBL] [Abstract][Full Text] [Related]
15. Can a toxin gene NAAT be used to predict toxin EIA and the severity of
Garvey MI; Bradley CW; Wilkinson MAC; Holden E
Antimicrob Resist Infect Control; 2017; 6():127. PubMed ID: 29270290
[TBL] [Abstract][Full Text] [Related]
16. Effect of testing methods on incidence of
McCauley BP; Evans ME; Simbartl LA; Gamage SD; Kralovic SM; Roselle GA
Infect Control Hosp Epidemiol; 2021 Apr; 42(4):461-463. PubMed ID: 33185177
[TBL] [Abstract][Full Text] [Related]
17. Comparison of testing approaches for Clostridium difficile infection at a large community hospital.
Grein JD; Ochner M; Hoang H; Jin A; Morgan MA; Murthy AR
Clin Microbiol Infect; 2014 Jan; 20(1):65-9. PubMed ID: 23521523
[TBL] [Abstract][Full Text] [Related]
18. Clinical and economic impact of the introduction of a nucleic acid amplification assay for Clostridium difficile.
Guinta MM; Bunnell K; Harrington A; Bleasdale S; Danziger L; Wenzler E
Ann Clin Microbiol Antimicrob; 2017 Dec; 16(1):77. PubMed ID: 29202797
[TBL] [Abstract][Full Text] [Related]
19. Trends in Clostridioides difficile diagnosis before and after a change in testing algorithm.
Turner DP; Thorburn SJ; Crowe A; Jardine D; Timmins C
J Microbiol Methods; 2021 May; 184():106189. PubMed ID: 33689797
[TBL] [Abstract][Full Text] [Related]
20. The Clinical and Laboratory Impact of Upgrading Clostridioides (formerly Clostridium) difficile Infection Testing from Routine to Molecular Based-Algorithm: an Observational Case-Study from the Eastern Province, Saudi Arabia.
Alnimr A; Alwazzeh MJ; Al-Ameer A
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
